Purpose Transsphenoidal surgery (TSS) is the first-line treatment for Cushing's disease
(CD). This review aimed to synthesize the remission and recurrence rates following TSS for …

Purpose Surgical experience is considered paramount for excellent outcome of
transsphenoidal surgery (TSS). However, objective data demonstrating the surgical success …

Transsphenoidal surgery is the first‐line treatment for Cushing's disease to selectively
remove the tumor. The rate of postoperative remission is estimated around 70%–80% in …

Background Endocrine neoplasms are generally slow-growing tumors that can show
hormonal activity and give metastases. In most cases they are benign and clearly malignant …

Pituitary surgery is the first-line treatment for patients with Cushing's disease. For patients
who are not considered candidates for pituitary surgery, pituitary radiation and bilateral …

Introduction Cushing's disease (CD) is rare disorder that should be adequately managed to
optimize long-term prognosis. Treatment of CD is multidisciplinary and often includes …

Context Adrenocorticotropin (ACTH)-secreting pituitary tumors (ACTHomas) are associated
with severe comorbidities and increased mortality. Current treatments mainly focus on …

Background: Cushing disease (CD) represents the principal cause of endogenous
hypercortisolism. The first-line therapy of CD is surgical removal of the ACTH-secreting …

Background First-line therapy of Cushing disease (CD) is transsphenoidal surgery (TSS)
aimed to obtain a complete removal of the pituitary adenoma and remission of disease …

Introduction Stereotactic radiosurgery (SRS) is one of the treatment options for the
management of residual or recurrent secreting pituitary adenomas (PA). While the role of …